G-PUR® for Reduced Dietary Fumonisin Bioavailability

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This prospective, placebo-controlled, randomized, monocentric, double-blind, crossover study in healthy volunteers aims to assess the effect of a single dose of 2 g G-PUR® on bioavailability of dietary fumonisin and to evaluate safety and tolerability.
Epistemonikos ID: 35a03467915f40ccbbfb4db4d4d81c42d95aed22
First added on: May 07, 2024